Open0.881 | Close- |
Vol / Avg.394.367K / 598.280K | Mkt Cap63.308M |
Day Range0.857 - 0.881 | 52 Wk Range0.675 - 7.600 |
Kezar Life Sciences Stock (NASDAQ: KZR) stock price, news, charts, stock research, profile.
Open0.881 | Close- |
Vol / Avg.394.367K / 598.280K | Mkt Cap63.308M |
Day Range0.857 - 0.881 | 52 Wk Range0.675 - 7.600 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.350 | -0.320 | 0.0300 | ||||
REV | 7.000K |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.320 | -0.340 | -0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-12-04 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 20.00 |
2023-11-27 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 20.00 |
2023-11-14 | Wells Fargo | Derek Archila | Maintains | Equal-WeightEqual-Weight | Lowers | 4.00 | 2.00 |
2023-10-12 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
KZR | Kezar Life Sciences | 0.17% | 63.3M |
CNTB | Connect Biopharma Hldgs | -4.39% | 52.5M |
FGEN | FibroGen | 4.28% | 59.5M |
CLGN | CollPlant Biotechnologies | -1.45% | 62.1M |
ACET | Adicet Bio | 3.44% | 58.5M |
You can purchase shares of Kezar Life Sciences (NASDAQ: KZR) through any online brokerage.
Other companies in Kezar Life Sciences’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), FibroGen (NASDAQ:FGEN), CollPlant Biotechnologies (NASDAQ:CLGN), Adicet Bio (NASDAQ:ACET) and OKYO Pharma (NASDAQ:OKYO).
The latest price target for Kezar Life Sciences (NASDAQ: KZR) was reported by HC Wainwright & Co. on Monday, December 4, 2023. The analyst firm set a price target for 20.00 expecting KZR to rise to within 12 months (a possible 2196.47% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Kezar Life Sciences (NASDAQ: KZR) is $0.8709 last updated Today at December 7, 2023 at 5:17 PM UTC.
There is no dividend information for Kezar Life Sciences.
Kezar Life Sciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Kezar Life Sciences.
Kezar Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.